Special Issue "Epilepsy: From Physiopathology to Improvements in Diagnosis and Therapy"
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 4189
2. Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA
Interests: neurodegeneration; neuroimmunomodulation
Epilepsy describes a heterogenous group of disorders having in common their tendency to produce seizures. Recent advances in the basic neurosciences provided new insights into the physiopathology of epilepsy. In recent years, revisions of the classification schemata have led to improvements in the recognition of seizure types and diagnosis. New therapeutic options for seizure treatment, including the withdrawal of anticonvulsants from patients who should probably not be treated with these drugs. Surgical management is an increasingly employed therapeutic strategy.
We invite investigators to contribute original research as well as review articles addressing recent advances on aspects regarding epilepsy physiopathology and improvements in its diagnosis. At the same time, research aiming to improve our understanding of the molecular mechanisms of epilepsy treatments is welcome. Original, high-quality contributions that are not yet published or that are not currently under review by other journals or peer-reviewed conferences are welcome
Dr. Clarissa Fantin Cavarsan
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- epileptic syndrome